摘要:
A capability is provided for reducing response variance of virtual processors. A controller receives a processing request. The controller may propagate the processing request toward multiple virtual processors hosted on multiple hardware devices contemporaneously. The controller may propagate the processing request toward a first virtual processor hosted on a first hardware device and propagate the processing request toward a second virtual processor hosted on a second hardware device based on a determination that a timeout period expires before a processing response is received from the first virtual processor. The timeout period may be determined based on one or more response time statistics of the virtual processor and one or more response time statistics of a physical processor.
摘要:
In one embodiment, the method includes receiving a pilot signal from a terminal at a target antenna of the plurality of antennas of the network element, determining an uplink channel estimate for the target antenna based on the received pilot signal, and obtaining a calibration coefficient associated with the target antenna. The calibration coefficient is based on a channel estimate between the target antenna and a different one of the plurality of antennas. The method further includes beamforming a transmission to the terminal using at least the target antenna based on the determined uplink channel estimate and the obtained calibration coefficient.
摘要:
Methods and apparatus for the automated updating of forwarding preferences for communications in a telecommunications network. In one embodiment, the network includes a wireless (e.g., cellular) network with user mobile user devices configured to detect a change to their configuration (such as a user changing out SIM cards or virtual access clients). In response, the device causes an update to its associated communication forwarding preferences to reflect the change. If the configuration alteration meets certain criteria (e.g., changes the phone number at which the device may be reached), the device sends a forwarding message instructing a network entity (e.g., routing server) to direct communications addressed to the old phone number to the new phone number. Thus, a user with two or more user profiles (such as two different carrier accounts) may be reached at any number associated with any of the profiles, even if only one profile is currently active.
摘要:
A method for transmission of map/reduce data in a data center having a storage network (SAN), the data center including multiple servers deployed with a job tracker, map task trackers and reduce task trackers, the method comprising: in response to receiving a map task allocated by the job tracker, a map task tracker performing the map task and generating map task outputs; the map task tracker writing the map task outputs to the storage network; and in response to receiving a reduce task allocated by the job tracker, a reduce task tracker reading the map tasks outputs from the storage network.
摘要:
Method to calculate time weight in an RDF graph, including: providing one or more triples of the RDF graph to an inference engine module, the one or more triples comprising a time information; providing a reference time to the inference engine; calculating an elapsed time from the reference time to the time value; and inversely weighting the time information by the elapsed time to provide a calculated time weight. Another embodiment may provide a method to update a time weight of a relation when an RDF graph has been added to or deleted from the relation. Another embodiment may provide a method to update a time weight of a relation represented by an RDF graph, when a new reference timestamp is provided. Another embodiment may provide a system to calculate time weight in an RDF graph.
摘要:
The invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein R1-3, R5-7, a, X, Y, Y′, Y″, and Z are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.
摘要:
In one embodiment, the method includes determining if a next interval of a bandwidth is available if an interval of the bandwidth preceding the next interval was determined to be available such that the next interval is larger than the preceding interval.
摘要:
The use of levo-ornidazole in the preparation of medicine for preventing and treating the anti-anaerobic bacteria infection is provided. It is demonstrated that levo-ornidazole exhibits lower toxicity and less central inhibition effects than dextro-ornidazole or racemic ornidazole. L-ornidazole possesses pharmacokinetics characteristics, which are superior to that of the racemic ornidazole, and anti-anaerobic activities which are slightly better than or substantially the same as that of the racemic ornidazole. Also, this invention particularly relates to a preparation process, which comprises formulating L-ornidazole as anti-anaerobic infection pharmaceutical preparations, which are suitable for clinical uses.
摘要:
Novel thin film optical filters have an integral air layer. The frustrated total internal reflection (FTIR) phenomenon, combined with thin film interference, is used to effectively control the polarization properties of thin film coatings operating at oblique angles. The invention is applicable to high-performance thin film polarizing beam-splitters, non-polarizing beam-splitters, non-polarizing cut-off filters and non-polarizing band-pass filters, and any other thin film coatings that require the control of polarization effect. The low index layer offers an improvement in performance and the simplification of the thin film optical filter coating designs by reducing the total number of layers and the total layer thicknesses to minimize the angles of incidence and the size of the filter substrates, thereby minimizing the contact area and hence reducing the manufacturing costs.
摘要:
The invention provides compounds of the formula: in salt or zwitterionic form or a pharmaceutically acceptable salt thereof, wherein R1-6, a, Z and Q are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.